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Results and Discussion
As described in the previous paper,1) the administration of As-I (0.5 mg/kg/d) caused 50% inhibition of Sarcoma-180 tumor growth. This inhibitory effect, however, might in part have derived from allograft rejection because of the difference of major histocompatibility antigen (MHA) between the tumor cells and host cells. Thus, in the present study, IMC carcinoma tumors in CDF1 mice and MM-46 carcinoma tumors in C3H mice were used as syngeneic tumor systems with the same MHA. As-I was injected i.p. at the daily dose of 0.1 or 0.5 mg/kg for 10 d and the inhibition of tumor growth was determined. As shown in Table I 
